Lack of Effect of Cholestyramine on the Pharmacokinetics of Clofibrate in Man
- 1 April 1975
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 5 (2) , 177-185
- https://doi.org/10.1111/j.1365-2362.1975.tb02284.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Mechanism of the Hypolipemic Effect of Clofibrate in Postabsorptive ManJournal of Clinical Investigation, 1973
- Interruption of the enterohepatic circulation of digitoxin by cholestyramineJournal of Clinical Investigation, 1971
- Combined Use of Clofibrate and Cholestyramine or DEAE Sephadex in HypercholesterolaemiaBMJ, 1971
- Long-Term Effects of Clofibrate (Atromid-S) on Serum Lipids in ManCirculation, 1969
- Reduction of serum triglycerides and cholesterol by ethyl p-chlorophenoxyisobutyrate (CPIB)The American Journal of Cardiology, 1965
- Serial Studies on the Metabolism of Human Adipose Tissue. I. Lipogenesis and Free Fatty Acid Uptake and Release in Small Aspirated Samples of Subcutaneous Fat *Journal of Clinical Investigation, 1964
- EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATEThe Lancet, 1962
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962
- The mechanism of glucuronide formationBiochemical Pharmacology, 1961
- Synthesis of glucuronides and of uridine diphosphate glucuronic acid in kidney cortex and gastric mucosaBiochimica et Biophysica Acta, 1959